CY1115089T1 - Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας - Google Patents

Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας

Info

Publication number
CY1115089T1
CY1115089T1 CY20141100109T CY141100109T CY1115089T1 CY 1115089 T1 CY1115089 T1 CY 1115089T1 CY 20141100109 T CY20141100109 T CY 20141100109T CY 141100109 T CY141100109 T CY 141100109T CY 1115089 T1 CY1115089 T1 CY 1115089T1
Authority
CY
Cyprus
Prior art keywords
diversity
lactobacillus plantarum
person
bacterial diversity
sibo
Prior art date
Application number
CY20141100109T
Other languages
English (en)
Inventor
Göran Molin
Siv Ahrne
Caroline Karlsson
Bengt Jeppsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of CY1115089T1 publication Critical patent/CY1115089T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Αποκαλύπτεται η χρήση στελέχους Lactobacillus plantarum για την παραγωγή σύνθεσης για την αύξηση της ποικιλότητας του γαστρεντερικού σωλήνα με χορήγηση του εν λόγω στελέχους σε ένα άτομο με σκοπό την παραγωγή αυξημένου δείκτη ποικιλότητας σε σύγκριση με placebo, καθώς και η χρήση στελέχους Lactobacillus plantarum για την παραγωγή σύνθεσης για την προφυλακτική θεραπεία υγιούς ατόμου έναντι της εμφάνισης χαμηλής βακτηριακής ποικιλότητας (LBD), ατόμου που έχει LBD έναντι της εμφάνισης μιας ή περισσότερων φυσιολογικώς διαταραγμένων καταστάσεων, βακτηριακής υπερανάπτυξης παχέος εντέρου (LIBO) ή βακτηριακής υπερανάπτυξης λεπτού εντέρου (SIBO), και ενός ατόμου που έχει LIBO ή SIBO έναντι της εμφάνισης μιας ή περισσότερων φυσιολογικώς διαταραγμένων καταστάσεων, και μέθοδος για την αύξηση της εν λόγω ποικιλότητας.
CY20141100109T 2007-03-01 2014-02-12 Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας CY1115089T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0700551 2007-03-01
EP08741827.3A EP2136825B1 (en) 2007-03-01 2008-02-29 Use of lactobacillus plantarum for increasing bacterial diversity

Publications (1)

Publication Number Publication Date
CY1115089T1 true CY1115089T1 (el) 2016-12-14

Family

ID=39673143

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100109T CY1115089T1 (el) 2007-03-01 2014-02-12 Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας

Country Status (19)

Country Link
US (1) US8586026B2 (el)
EP (1) EP2136825B1 (el)
JP (2) JP5829005B2 (el)
KR (1) KR101510691B1 (el)
CN (1) CN101674840B (el)
AU (1) AU2008219818B2 (el)
BR (1) BRPI0808522A8 (el)
CA (1) CA2679480C (el)
CY (1) CY1115089T1 (el)
DK (1) DK2136825T3 (el)
ES (1) ES2446942T3 (el)
HR (1) HRP20140080T1 (el)
NZ (1) NZ579330A (el)
PL (1) PL2136825T3 (el)
PT (1) PT2136825E (el)
RU (1) RU2521364C2 (el)
SI (1) SI2136825T1 (el)
WO (1) WO2008105715A2 (el)
ZA (1) ZA200906534B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP2600877A4 (en) * 2010-08-04 2014-05-07 Borody Thomas J COMPOSITIONS FOR FLORAL TRANSPLANTATION OF FECAL MATERIALS AND METHODS OF MAKING AND USING SAME, AND DEVICES FOR THEIR ADMINISTRATION
HK1253538A1 (zh) * 2010-08-04 2019-06-21 Borody Thomas J 用於糞便菌群植入的組合物及其製備和使用方法
JP2014507481A (ja) 2011-03-09 2014-03-27 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 結腸微生物相移植のための組成物及び方法
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
KR102561989B1 (ko) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
AU2016268158B2 (en) 2015-05-22 2022-03-17 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
RU2628063C1 (ru) * 2016-09-22 2017-08-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогнозирования транслокации E.coli из кишечника при некультивируемом типе инфекционного процесса в эксперименте на кроликах
RU2642327C1 (ru) * 2016-10-06 2018-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза развития патогенетического процесса по некультивируемому или культивируемому типу в эксперименте
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3630190B1 (en) 2017-05-26 2024-02-21 Finch Therapeutics Holdings LLC Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
GB201709763D0 (en) * 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
US11865145B2 (en) 2017-08-07 2024-01-09 Finch Therapeutics Holdings Llc Compositions and methods for maintaining and restoring a healthy gut barrier
EP3790995A1 (en) * 2018-05-08 2021-03-17 F. Hoffmann-La Roche AG Method of cancer prognosis by assessing tumor variant diversity by means of establishing diversity indices
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
TWI706783B (zh) * 2018-07-18 2020-10-11 大江生醫股份有限公司 延緩老化之益生菌株及其組合物與用途
US11911419B2 (en) 2018-09-27 2024-02-27 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders
CA3161418C (en) 2019-12-17 2024-05-21 Noelle Marie PATNO Multi-strain probiotic composition and its use
FR3122084B1 (fr) 2021-04-21 2023-10-27 Mirei Int Ltd Composition cosmétique ou pharmaceutique caractérisée par une association de bioactifs sélectionnés à partir de graines deGlycine max pour son utilisation dans la modulation du microbiote intestinal et cutanée et l’équilibre de l’axe intestin-peau-cerveau.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
RU2247148C2 (ru) * 2002-05-28 2005-02-27 Пименов Евгений Васильевич Штамм бактерий lactobacillus plantarum p4, штамм бактерий lactobacillus buchneri p0 и препарат-пробиотик на их основе для коррекции дисбактериозов различной этиологии у людей и животных
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP4320408B2 (ja) * 2005-04-21 2009-08-26 学校法人明治大学 胆汁酸結合能を有する新規菌株
GB0513556D0 (en) 2005-07-01 2005-08-10 Matforsk As Product
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption

Also Published As

Publication number Publication date
CA2679480C (en) 2016-10-18
PT2136825E (pt) 2014-02-21
JP2015164952A (ja) 2015-09-17
SI2136825T1 (sl) 2014-04-30
JP6162749B2 (ja) 2017-07-12
AU2008219818B2 (en) 2013-06-27
RU2521364C2 (ru) 2014-06-27
WO2008105715A2 (en) 2008-09-04
JP2010520234A (ja) 2010-06-10
BRPI0808522A2 (pt) 2015-02-10
RU2009136328A (ru) 2011-04-10
US8586026B2 (en) 2013-11-19
DK2136825T3 (da) 2014-02-24
US20100143463A1 (en) 2010-06-10
AU2008219818A1 (en) 2008-09-04
EP2136825B1 (en) 2013-11-20
WO2008105715A3 (en) 2008-10-30
KR101510691B1 (ko) 2015-04-10
HRP20140080T1 (hr) 2014-03-14
CN101674840A (zh) 2010-03-17
KR20090127415A (ko) 2009-12-11
ZA200906534B (en) 2010-11-24
PL2136825T3 (pl) 2014-04-30
CN101674840B (zh) 2014-05-21
ES2446942T3 (es) 2014-03-10
CA2679480A1 (en) 2008-09-04
EP2136825A2 (en) 2009-12-30
BRPI0808522A8 (pt) 2017-10-10
JP5829005B2 (ja) 2015-12-09
NZ579330A (en) 2012-02-24

Similar Documents

Publication Publication Date Title
CY1115089T1 (el) Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας
ECSP13012776A (es) Inmunoglobulinas de dominio variable dual
WO2010141803A3 (en) Bioartificial lung
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
MX2011011670A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas.
MY151137A (en) Probiotics to improve gut microbiota
ECSP10010643A (es) Inmunoglobulinas duales de dominio variable y sus aplicaciones
JOP20220162A1 (ar) مشتقات كربوكسي ذات خصائص مضادة للالتهاب
UY31228A1 (es) Ariloxazoles sustituidos y su uso
FI20116007A (fi) Serotoniinitason nostaminen ja diagnostisointi
DE602007009382D1 (de) Stent mit variablem stauchdurchmesser
MX2010001692A (es) Ciertas entidades quimicas, composiciones y metodos.
EA201170219A1 (ru) Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
CY1120468T1 (el) Εξανθρωπισμενα αντισωματα il-25
MY151104A (en) Novel use
RU2014106509A (ru) Получение и применение бактериального гистамина
TN2013000249A1 (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
NZ588663A (en) Anti-viral nutraceutical
AU2019257492A1 (en) Novel compositions and methods for the treatment of immune related diseases
MX2013007099A (es) Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia.
ATE536102T1 (de) Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus
UY4350U (es) Cinta gimnástica de correr
JP1710368S (ja) エピテーゼ
AU319446S (en) Swing fitness device